Similarly, the healthy/benign patients had low Proseek® CA125 values (Fig. 1c, white) while the early/late stage ovarian cancer patients had high Proseek® CA125 values (Fig. 1c, black). This evidence concerns the gene MUC16 and ovarian cancer.